Sequence analysis of Plasmodium falciparum cytochrome b in multiple geographic sites

Malaria Journal

Volumn 6, Issue , 2007, Pages

  Ekala, Marie Thérèse ^a   Khim, Nimol ^b   Legrand, Eric ^c   Randrianarivelojosia, Milijaona ^d   Jambou, Ronan ^e   Fandeur, Thierry ^a,b   Menard, Didier ^d   Assi, Serge Brice ^f   Henry, Marie Claire ^f   Rogier, Christophe ^g   Bouchier, Christiane ^a   Mercereau Puijalon, Odile ^a  

^a INSTITUT PASTEUR   (France)

^b INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^c INSTITUT PASTEUR DE LA GUYANE   (French Guiana)

^d INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^e INSTITUT PASTEUR DE DAKAR   (Senegal)

^f Institut Pierre Richet Bouake   (Côte d’Ivoire)

^g SERVICE DE SANTÉ DES ARMÉES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CYTOCHROME B; MITOCHONDRIAL DNA; PROTOZOAL DNA;

ARTICLE; CODON; DNA POLYMORPHISM; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; MALARIA; MITOCHONDRIAL GENE; NUCLEOTIDE SEQUENCE; PFCYTB GENE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT FAILURE; AFRICA; AMINO ACID SUBSTITUTION; ANIMAL; ASIA; DRUG RESISTANCE; GENETIC POLYMORPHISM; GENETICS; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; PATHOLOGY; SOUTH AMERICA;

AFRICA; AMINO ACID SUBSTITUTION; ANIMALS; ASIA; CYTOCHROMES B; DNA, MITOCHONDRIAL; DNA, PROTOZOAN; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS; SOUTH AMERICA;

EID: 38849187113     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-6-164     Document Type: Article

References (54)

1. WHO Guidelines for the treatment of malaria. 2006 http://www.who.int/ malaria/diagnosisandtreatment.html
2. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. S Looareesuwan P Wilairatana K Chalermarut Y Rattanapong CJ Canfield DB Hutchinson, Am J Trop Med Hyg 1999 60 526 532 10348224
3. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. IK Srivastava JM Morrisey E Darrouzet F Daldal AB Vaidya, Mol Microbiol 1999 33 704 711 10.1046/j.1365-2958.1999.01515.x 10447880
4. Atovaquone resistance in malaria parasites. AB Vaidya MW Mather, Drug Resist Updat 2000 3 283 287 10.1054/drup.2000.0157 11498396
5. Cytochrome b mutations that modify the ubiquinol-binding pocket of the cytochrome bc1 complex and confer anti-malarial drug resistance in Saccharomyces cerevisiae. JJ Kessl KH Ha AK Merritt BB Lange P Hill B Meunier SR Meshnick BL Trumpower, J Biol Chem 2005 280 17142 17148 10.1074/jbc.M500388200 15718226
6. Molecular basis for atovaquone binding to the cytochrome bc1 complex. JJ Kessl BB Lange T Merbitz-Zahradnik K Zwicker P Hill B Meunier H Palsdottir C Hunte S Meshnick BL Trumpower, J Biol Chem 2003 278 31312 31318 10.1074/jbc.M304042200 12791689
7. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. M Korsinczky N Chen B Kotecka A Saul K Rieckmann Q Cheng, Antimicrob Agents Chemother 2000 44 2100 2108 10898682 10.1128/AAC.44.8.2100-2108.2000
8. Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum. HJ Painter JM Morrisey MW Mather AB Vaidya, Nature 2007 446 88 91 10.1038/nature05572 17330044
9. Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. IK Srivastava H Rottenberg AB Vaidya, J Biol Chem 1997 272 3961 3966 10.1074/jbc.272.52.33360 9020100
10. Structural features of Plasmodium cytochrome b that may underlie susceptibility to 8-aminoquinolines and hydroxynaphthoquinones. AB Vaidya MS Lashgari LG Pologe J Morrisey, Mol Biochem Parasitol 1993 58 33 42 10.1016/0166-6851(93)90088-F 8459834
11. A mechanism for the synergistic antimalarial action of atovaquone and proguanil. IK Srivastava AB Vaidya, Antimicrob Agents Chemother 1999 43 1334 1339 10348748
12. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker. B Schwobel M Alifrangis A Salanti T Jelinek, Malar J 2003 2 5 12665429 10.1186/1475-2875-2-5
13. Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria. PL Chiodini CP Conlon DB Hutchinson JA Farquhar AP Hall TE Peto H Birley DA Warrell, J Antimicrob Chemother 1995 36 1073 1078 10.1093/jac/36.6.1073 8821609
14. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. S Looareesuwan C Viravan HK Webster DE Kyle DB Hutchinson CJ Canfield, Am J Trop Med Hyg 1996 54 62 66 8651372
15. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. QL Fivelman GA Butcher IS Adagu DC Warhurst G Pasvol, Malar J 2002 1 1 12057021 10.1186/1475-2875-1-1
16. Detection of atovaquone and Malarone resistance conferring mutations in Plasmodium falciparum cytochrome b gene (cytb). JP Gil F Nogueira J Stromberg-Norklit J Lindberg M Carrolo C Casimiro D Lopes AP Arez PV Cravo VE Rosario, Mol Cell Probes 2003 17 85 89 10.1016/S0890-8508(03)00006-9 12788029
17. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana. M Muehlen J Schreiber S Ehrhardt R Otchwemah T Jelinek U Bienzle FP Mockenhaupt, Trop Med Int Health 2004 9 361 363 10.1111/j.1365-3156.2004.01201.x 14996365
18. Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola. S Pimentel F Nogueira C Benchimol V Quinhentos J Bom L Varandas V do Rosario L Bernardino, Malar J 2006 5 30 16597338 10.1186/1475-2875-5-30
19. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. O Wichmann N Muehlberger T Jelinek M Alifrangis G Peyerl-Hoffmann M Muhlen MP Grobusch J Gascon A Matteelli H Laferl Z Bisoffi S Ehrhardt J Cuadros C Hatz I Gjorup P McWhinney J Beran S da Cunha M Schulze H Kollaritsch P Kern G Fry J Richter, J Infect Dis 2004 190 1541 1546 10.1086/424469 15478057
20. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America. E Legrand M Demar B Volney MT Ekala M Quinternet C Bouchier T Fandeur C Rogier B Carme O Puijalon P Esterre, Antimicrob Agents Chemother 2007 51 2280 2281 17438062 10.1128/AAC.01532-06
21. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations. L Musset O Bouchaud S Matheron L Massias J Le Bras, Microbes Infect 2006 8 2599 2604 10.1016/j.micinf.2006.07. 011 16962361
22. Atovaquone/proguanil resistance in Africa: a case report. KP David M Alifrangis A Salanti LS Vestergaard A Ronn IB Bygbjerg, Scand J Infect Dis 2003 35 897 898 14723376
23. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports. A Farnert J Lindberg P Gil G Swedberg Y Berqvist MM Thapar N Lindegardh S Berezcky A Bjorkman, Bmj 2003 326 628 629 12649236 10.1136/bmj.326.7390.628
24. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa. S Kuhn MJ Gill KC Kain, Am J Trop Med Hyg 2005 72 407 409 15827276
25. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers. L Musset B Pradines D Parzy R Durand P Bigot J Le Bras, J Antimicrob Chemother 2006 57 110 115 10.1093/jac/dki420 16319183
26. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa. E Schwartz S Bujanover KC Kain, Clin Infect Dis 2003 37 450 451 10.1086/375599 12884171
27. Malarone treatment failure not associated with previously described mutations in the cytochrome b gene. O Wichmann M Muehlen H Gruss FP Mockenhaupt N Suttorp T Jelinek, Malar J 2004 3 14 15186499 10.1186/1475-2875-3-14
28. Tracing the dawn of Plasmodium falciparum with mitochondrial genome sequences. DJ Conway, Trends Genet 2003 19 671 674 10.1016/j.tig.2003.10.007 14642743
29. Origin of Plasmodium falciparum malaria is traced by mitochondrial DNA. DJ Conway C Fanello JM Lloyd BM Al-Joubori AH Baloch SD Somanath C Roper AM Oduola B Mulder MM Povoa B Singh AW Thomas, Mol Biochem Parasitol 2000 111 163 171 10.1016/S0166-6851(00)00313-3 11087926
30. Early origin and recent expansion of Plasmodium falciparum. DA Joy X Feng J Mu T Furuya K Chotivanich AU Krettli M Ho A Wang NJ White E Suh P Beerli XZ Su, Science 2003 300 318 321 10.1126/science.1081449 12690197
31. Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. X Su LA Kirkman H Fujioka TE Wellems, Cell 1997 91 593 603 10.1016/S0092-8674(00)80447-X 9393853
32. Maternal inheritance of extrachromosomal DNA in malaria parasites. A Creasey K Mendis J Carlton D Williamson I Wilson R Carter, Mol Biochem Parasitol 1994 65 95 98 10.1016/0166-6851(94)90118-X 7935632
33. Uniparental inheritance of the mitochondrial gene cytochrome b in Plasmodium falciparum. AM Creasey LC Ranford-Cartwright DJ Moore DH Williamson RJ Wilson D Walliker R Carter, Curr Genet 1993 23 360 364 10.1007/BF00310900 8467535
34. Maintenance and integrity of the mitochondrial genome: a plethora of nuclear genes in the budding yeast. V Contamine M Picard, Microbiol Mol Biol Rev 2000 64 281 315 10839818 10.1128/MMBR.64.2.281-315.2000
35. Frequency of drug resistance in Plasmodium falciparum: a nonsynergistic combination of 5-fluoroorotate and atovaquone suppresses in vitro resistance. S Gassis PK Rathod, Antimicrob Agents Chemother 1996 40 914 919 8849251
36. Complete nucleotide sequence of the 6 kb element and conserved cytochrome b gene sequences among Indian isolates of Plasmodium falciparum. I Sharma DS Rawat ST Pasha S Biswas YD Sharma, Int J Parasitol 2001 31 1107 1113 10.1016/S0020-7519(01)00218-1 11429175
37. Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia. T Gebru A Hailu PG Kremsner JF Kun MP Grobusch, Malar J 2006 5 112 17118179 10.1186/1475-2875-5-112
38. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa. CT Happi GO Gbotosho OA Folarin D Milner O Sarr A Sowunmi DE Kyle WK Milhous DF Wirth AM Oduola, Malar J 2006 5 82 17020611 10.1186/1475-2875-5-82
39. Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border. Y Naoshima-Ishibashi M Iwagami S Kawazu S Looareesuwan S Kano, Travel Med Infect Dis 2007 5 132 134 10.1016/j.tmaid.2006.07.002 17298921
40. Prevalence of Plasmodium falciparum cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance. A Berry A Senescau J Lelievre F Benoit-Vical R Fabre B Marchou JF Magnaval, Trans R Soc Trop Med Hyg 2006 100 986 988 10.1016/j.trstmh.2006.02.004 16690094
41. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. R Jambou E Legrand M Niang N Khim P Lim B Volney MT Ekala C Bouchier P Esterre T Fandeur O Mercereau-Puijalon, Lancet 2005 366 1960 1963 10.1016/S0140-6736(05)67787-2 16325698
42. Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia. N Khim C Bouchier MT Ekala S Incardona P Lim E Legrand R Jambou S Doung OM Puijalon T Fandeur, Antimicrob Agents Chemother 2005 49 3147 3152 16048916 10.1128/AAC.49.8.3147-3152.2005
43. Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas. H Bogreau F Renaud H Bouchiba P Durand SB Assi MC Henry E Garnotel B Pradines T Fusai B Wade E Adehossi P Parola MA Kamil O Puijalon C Rogier, Am J Trop Med Hyg 2006 74 953 959 16760503
44. Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment. D Menard D Djalle A Manirakiza F Yapou V Siadoua S Sana MD Matsika-Claquin M Nestor A Talarmin, Am J Trop Med Hyg 2005 73 239 243 16103582
45. PCR typing of field isolates of Plasmodium falciparum. H Contamin T Fandeur S Bonnefoy F Skouri F Ntoumi O Mercereau-Puijalon, J Clin Microbiol 1995 33 944 951 7790466
46. Base-calling of automated sequencer traces using Phred I. Accuracy Assessment. B Ewing LD Hillier MC Wendl P Green, Genome Res 1998 8 175 85 9521921
47. Metapopulation concepts applied to falciparum malaria and their impacts on the emergence and spread of chloroquine resistance. F Ariey JB Duchemin V Robert, Infect Genet Evol 2003 2 185 192 10.1016/S1567-1348(02)00099-0 12797980
48. Evolutionary paradigm of chloroquine-resistant malaria in India. A Das AP Dash, Trends Parasitol 2007 23 132 135 10.1016/j.pt.2007.01.012 17280870
49. Genetic diversity of Plasmodium falciparum shows geographical variation. A Creasey B Fenton A Walker S Thaithong S Oliveira S Mutambu D Walliker, Am J Trop Med Hyg 1990 42 403 413 2187364
50. Invasion of Africa by a single pfcrt allele of South East Asian type. F Ariey T Fandeur R Durand M Randrianarivelojosia R Jambou E Legrand MT Ekala C Bouchier S Cojean JB Duchemin V Robert J Le Bras O Mercereau-Puijalon, Malar J 2006 5 34 16638153 10.1186/1475-2875-5-34
51. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. JF Cortese A Caraballo CE Contreras CV Plowe, J Infect Dis 2002 186 999 1006 10.1086/342946 12232841
52. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. DA Fidock T Nomura AK Talley RA Cooper SM Dzekunov MT Ferdig LM Ursos AB Sidhu B Naude KW Deitsch XZ Su JC Wootton PD Roepe TE Wellems, Mol Cell 2000 6 861 871 10.1016/S1097-2765(05)00077-8 11090624
53. Recombination hotspots and population structure in Plasmodium falciparum. J Mu P Awadalla J Duan KM McGee DA Joy GA McVean XZ Su, PLoS Biol 2005 3 e335 16144426 10.1371/journal.pbio.0030335
54. Extense variant gene family repertoire overlap in Western Amazon Plasmodium falciparum isolates. L Albrecht EF Merino EH Hoffmann MU Ferreira RG de Mattos Ferreira AL Osakabe RC Dalla Martha M Ramharter AM Durham JE Ferreira HA del Portillo G Wunderlich, Mol Biochem Parasitol 2006 150 157 165 10.1016/j.molbiopara.2006.07.007 16938359